IOMP SCHOOL WEBINARS 2024

🎓
Download your CPD certificate
Only participants who attended a webinar in full are eligible for the certificate.
Get Certificate →
🕐 Convert webinar times to your local time zone: Greenwich Mean Time converter   🎓 Certificate queries: certificates page
Browse by year
All webinars 2024 — recordings available
Dec
11
2024
The Use of AI to Improve Access to High-Quality Radiation Therapy Planning in Low- and Middle-Income Countries
Wed 11 Dec · 12:00 GMT · 1 hour · 3 speakers
 AI-based Tools for Radiotherapy in LMICs — Court · Marquez · Trauernicht
▶ Recording1 CPD point
Date & time
Wed 11 Dec 2024 · 12:00 GMT
Duration
1 hour
CPD / CE
1 CPD point
Organizer
Moderator
M. Mahesh, Chair of IOMP Science Committee
AI to Improve Access to High-Quality RT Planning in LMICs
Laurence Court, PhD (MD Anderson) · Barbara Marquez (MD Anderson) · Christoph Trauernicht, PhD (Tygerberg Hospital / Stellenbosch University)
▼ Abstract
Advances in AI are going to affect all aspects of radiation therapy, including contouring, treatment planning, and quality assurance. This presentation describes efforts to develop and expand AI tools specifically for clinics in low- and middle-income countries, covering expected quality and efficiency gains of these tools, possible risks in deployment and how to mitigate them, and lessons learned in clinical deployment.
▼ Speaker biography
Laurence Court, PhD
Laurence Court, PhD leads a team focused on development and clinical deployment of AI-based tools to support radiotherapy teams in LMICs. Their flagship product is the Radiation Planning Assistant, which received FDA 510(k) clearance in 2023 and is currently starting clinical use in South Africa.
Barbara Marquez
Barbara Marquez is a PhD candidate at MD Anderson Cancer Center. Her research leverages AI to improve peer review of CT-based contours for radiotherapy in head & neck and gynecological cancers.
Christoph Trauernicht, PhD
Christoph Trauernicht, PhD is Head of the Medical Physics Division at Tygerberg Hospital, Cape Town, and Senior Lecturer at Stellenbosch University. He leads a team of five medical physicists, two radiographers, and several medical physics clinical training posts.
Learning objectives:
  1. Describe how AI is likely to improve access to high-quality radiotherapy planning worldwide.
  2. Understand risks when implementing AI into clinical practice and possible ways to reduce them.
  3. Understand challenges in implementing AI tools in LMICs.
Oct
28
2024
Why Radiation Oncology Clinical Trials Need Medical Physicists
Mon 28 Oct · 12:00 GMT · 1 hour · 2 speakers
 The Role of Medical Physicists in Radiation Oncology Clinical Trials — Prof. Søren M. Bentzen & Prof. Tomas Kron
▶ Recording1 CPD point
Date & time
Mon 28 Oct 2024 · 12:00 GMT
Duration
1 hour
CPD / CE
1 CPD point
Organizer
Moderators
Wayne Beckham & Kwan Hoong Ng
Why Radiation Oncology Clinical Trials Need Medical Physicists
Søren M. Bentzen, PhD, D.M.Sc. (University of Maryland) · Tomas Kron, OAM, PhD (Peter MacCallum Cancer Centre)
▼ Abstract
Randomized controlled trials (RCTs) remain the gold standard for establishing causality between an intervention and a clinical outcome. Medical physicists play an essential role in reducing patient-to-patient variability in exposure. Key roles include defining the technical details of the radiotherapy approach, independent credentialling of centres, developing QA programs, supporting automated data collection and curation, and developing trial questions that identify the role of techniques or technologies in improving outcomes.
▼ Speaker biography
Prof. Søren M. Bentzen, PhD, D.M.Sc.
Prof. Søren M. Bentzen, PhD, D.M.Sc. is Professor and Director of the Division of Biostatistics and Bioinformatics, and Professor of Radiation Oncology at the University of Maryland School of Medicine. He has published 550 papers with 50,000 citations and an h-index of 112. He is one of only 3 individuals awarded both the ASTRO and ESTRO Gold Medals.
Prof. Tomas Kron, OAM, PhD
Prof. Tomas Kron, OAM, PhD is Director of Physical Sciences at Peter MacCallum Cancer Centre, Melbourne, leading a team of ~50 engineers and physicists. He has delivered 100+ invited conference presentations and published 350+ papers in refereed journals. He received an Order of Australia Medal for services to science and medicine.
Learning objectives:
  1. Be aware of different approaches to clinical trials.
  2. Understand the importance of clinical trials for generation of evidence in radiation oncology.
  3. Appreciate the multiple roles medical physicists can have in clinical trials.
Jul
3
2024
Advancing Radiation Safety in Medicine: Insights from IOMP and UNSCEAR on Ionizing Radiation Exposure
Wed 3 Jul · 12:00 GMT · 1 hour · 2 speakers
 IOMP’s Role in Enhancing Radiation Safety in Medical Practices — Prof. John Damilakis, IOMP President
 Insights from UNSCEAR’s 2020/2021 Report on Medical Exposure — Dr. Peter Thomas, ARPANSA
▶ Recording1 CPD point
Date & time
Wed 3 Jul 2024 · 12:00 GMT
Duration
1 hour
CPD / CE
1 CPD/CME point
Organizer
John Damilakis, President IOMP
Moderator
John Damilakis, President IOMP
Title 1: IOMP’s Role in Enhancing Radiation Safety in Medical Practices
John Damilakis, MSc, PhD, FIOMP, FIUPESM — President, IOMP
▼ Abstract
A short introduction presenting IOMP’s role in enhancing radiation safety across medical practices globally, key areas of focus in ionizing radiation medical exposure, and the importance of collecting data related to frequency, distribution, and trends of radiation usage in medical diagnostics and treatment.
▼ Speaker biography
John Damilakis
John Damilakis is a professor and director of the Department of Medical Physics at the University of Crete and IOMP President. He is a member of ICRP Committee 3, Chair of IUPAP AC4, and a participant in the steering committee of the EuroSafe Imaging Campaign. He has published 260 research articles with 9,728 citations and an h-index of 53.
Title 2: Insights and Future Directions in Medical Radiation Exposure — UNSCEAR 2020/2021 Report
Dr. Peter Thomas — Director, Medical Imaging Section, ARPANSA, Australia
▼ Abstract
A detailed presentation focusing on the comprehensive UNSCEAR 2020/2021 Report: "Evaluation of Medical Exposure to Ionizing Radiation." The webinar equips participants with insights into the global state of medical radiation practices, advancements in the field, and upcoming UNSCEAR evaluations.
▼ Speaker biography
Dr. Peter Thomas
Dr. Peter Thomas is Director of the Medical Imaging section at ARPANSA, running Australia’s National Diagnostic Reference Level Service. He chaired the UNSCEAR Expert Group on Medical Exposures from 2019–2020, was lead writer for the 2020/2021 UNSCEAR report, and has been a member of the Australian delegation to UNSCEAR since 2005.
Jun
20
2024
Advancements in Imaging for Radiation Therapy & Patient-Specific QA in IMRT
Thu 20 Jun · 12:00 GMT · 1 hour · 2 speakers
 Title 1: Advancements in Imaging for Radiation Therapy — Dr. Hassaan Alkhatib, PhD, FAAPM, DABR
 Title 2: Patient Specific QA in IMRT — Dr. Sudesh Deshpande, PhD
▶ Recording1 CPD point
Date & time
Thu 20 Jun 2024 · 12:00 GMT
Duration
1 hour
CPD / CE
1 CPD point
Organizer
Eva Bezak
Moderator
Ibrahim Duhaini
Title 1: Advancements in Imaging for Radiation Therapy
Dr. Hassaan Alkhatib, PhD, FAAPM, DABR, AABMP — Chief Physicist, South Carolina Oncology Associates, Columbia SC, USA
▼ Abstract
This seminar explores the latest developments in imaging technologies for optimizing radiation therapy treatments. Topics include fundamentals of imaging modalities (X-ray, CT, MRI, PET, ultrasound), image acquisition and reconstruction techniques, image-guided radiation therapy (IGRT), adaptive radiotherapy, and functional imaging for treatment response assessment.
▼ Speaker biography
Dr. Hassaan Alkhatib
Dr. Hassaan Alkhatib earned his doctorate from the University of North Dakota and completed his Medical Physics Residency at the University of Minnesota. He has been Chief of Medical Physics at Richland Memorial Hospital since 2005 and Associate Professor at the University of South Carolina since 2010. He is board certified by AABMP and ABR.
Title 2: Patient Specific QA in IMRT
Dr. Sudesh Deshpande, PhD — Chief Medical Physicist, P.D. Hinduja National Hospital and Research Center, Mumbai
▼ Abstract
Patient-specific quality assurance (PSQA) in IMRT is an important step to ensure treatment accuracy and patient safety. The presentation covers the choice of detectors for point dose and 2D dose distribution measurements, use of AAPM TG-218 for PSQA analysis with 3%/2mm gamma criteria, and tips, tricks, and new trends in PSQA.
▼ Speaker biography
Dr. Sudesh Deshpande
Dr. Sudesh Deshpande has 27 years of experience in medical physics. He has been Chief Medical Physicist at P.D. Hinduja National Hospital since 2006, is a member of the Executive Committee of AMPI (2024–2027), and a member of the Education and Training Committee of AFOMP (2023–2025). He has 25 publications.
Learning objectives:
  1. Understand the importance of Patient Specific QA in IMRT.
  2. Choose appropriate detectors for point dose and 2D dose distribution measurements.
  3. Use AAPM TG-218 for PSQA analysis.
May
29
2024
Quality Assurance in Radiation Therapy
Wed 29 May · 12:00 GMT · 1 hour · Prof. Alexandru Dasu
 Quality Assurance in Radiation Therapy: Rationale, Methodology and Continuous Improvement — Alexandru Dasu, The Skandion Clinic / Uppsala University
▶ Recording1 CPD point
Date & time
Wed 29 May 2024 · 12:00 GMT
Duration
1 hour
CPD / CE
1 CPD/CME point
Organizer
Eva Bezak, Vice President IOMP
Moderator
Eva Bezak, Vice President IOMP
Quality Assurance in Radiation Therapy
Alexandru Dasu — Chief Medical Physicist, The Skandion Clinic, Uppsala, Sweden · Department of Immunology, Genetics and Pathology, Uppsala University
▼ Abstract
Radiation therapy is a multi-disciplinary, multi-step treatment using complex equipment and techniques. Variations above 5% of dose can lead to significant changes in local control or complication rates. This presentation reviews the rationale for quality assurance in radiation therapy, the particular requirements of RT versus radiation protection, the steps to build a QA system, and examples of continuous improvement.
▼ Speaker biography
Alexandru Dasu
Alexandru Dasu is Chief Medical Physicist at the Skandion Clinic — the national proton therapy centre in Uppsala, Sweden — and is academically affiliated to Uppsala University. He studied Medical Physics at Umeå University where he received his PhD in 2001, and combines clinical activities with research and education in proton therapy, radiation dosimetry, and QA.
Mar
8
2024
Celebrating International Women’s Day with Early Career Medical Physicists
Fri 8 Mar · 12:00 GMT · 1 hour · 3 speakers
 In vitro Development of MUC1-CE Targeted Alpha Therapy for Pancreatic Cancer — Ashleigh Hull
 Exploring Ultra-high Dose Rate Radiation and Growing as an Educator — Ashley Cetnar, PhD
 Making Progress Only Needs to Get Started — Leticia Irazola Rosales
▶ Recording1 CPD point
Date & time
Fri 8 Mar 2024 · 12:00 GMT
Duration
1 hour
CPD / CE
1 CPD/CME point
Organizers
Loredana Marcu, Eva Bezak & Kathleen Hintenlang
Moderator
Loredana Marcu
Talk 1: In vitro Development of MUC1-CE Targeted Alpha Therapy for Pancreatic Ductal Adenocarcinoma
Ashleigh Hull — Lecturer in Nuclear Medicine & PhD candidate, University of South Australia · Nuclear Medicine Technologist, Royal Adelaide Hospital
▼ Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy and a leading cause of cancer-related death worldwide. A novel alpha-emitting radioimmunoconjugate, 225Ac-DOTA-C595, was developed to target PDAC by binding to cancer-specific mucin 1 epitopes (MUC1-CE), which is overexpressed on over 90% of PDAC tissues. A series of in vitro assays were performed to evaluate cell binding, internalisation and cytotoxicity, establishing the feasibility of using this radioimmunoconjugate for PDAC treatment.
▼ Speaker biography
Ashleigh Hull
Ashleigh Hull is a Lecturer in Nuclear Medicine and PhD candidate at the University of South Australia. Her research focuses on development and characterisation of novel radioimmunoconjugates for the diagnosis and treatment of cancer, leading to two novel therapeutic radioimmunoconjugates capable of treating pancreatic cancer at an in vitro level.
Talk 2: Exploring Ultra-high Dose Rate Radiation and Growing as an Educator in Medical Physics
Ashley Cetnar, PhD — Assistant Professor of Radiation Oncology, The Ohio State University
▼ Abstract
Dr. Cetnar shares her research journey in ultra-high dose rate (FLASH) radiation therapy, including commissioning of new technology, exploration of dosimetry methods, and biological experiments at two ultra-high dose rate generating devices at Ohio State. She also discusses her pathway to completing a PhD in Education and her passion for medical physics education research.
▼ Speaker biography
Dr. Ashley Cetnar
Dr. Ashley Cetnar is an Assistant Professor in the Department of Radiation Oncology at The Ohio State University, trained as both a clinical medical physicist and expert in teaching and learning. She is passionate about helping others learn and grow as both individuals and within a team.
Talk 3: Making Progress Only Needs to Get Started
Leticia Irazola Rosales — Medical Physicist, Centro de Investigaciones Biomédicas de La Rioja, Spain
▼ Abstract
A personal reflection on how passion and love for what you do transforms a career in medical physics. Leticia shares her journey from physics student to clinical medical physicist and leader, demonstrating that progress is made by simply getting started and embracing the opportunities that come along the way.
▼ Speaker biography
Leticia Irazola Rosales
Leticia Irazola Rosales studied Physics at the University of Zaragoza, earned her MSc at the University of Rennes I and PhD at the University of Sevilla, and completed a postdoc at Pontificia Universidad Católica de Chile. She currently combines clinical medical physics with university teaching and research in La Rioja, Spain. She is Secretary of the EFOMP Early Career SIG.
Feb
22
2024
Patient Radiation Safety: Meet the IOMP Corporate Members
Thu 22 Feb · 12:00 GMT · 1 hour · 2 speakers
 LUNA 3D – The New More in Surface Guided Radiation Therapy by LAP — Delena Hanson, LAP America
 Sun Nuclear: Your Trusted Partner for Patient Safety — Greg Martin, MSc
▶ Recording1 CPD point
Date & time
Thu 22 Feb 2024 · 12:00 GMT
Duration
1 hour
CPD / CE
1 CPD/CME point
Organizer
John Damilakis
Moderators
John Damilakis & Magdalena Stoeva
Title 1: LUNA 3D – The New More in Surface Guided Radiation Therapy by LAP
Delena Hanson, MSRT, RTT, CSPO, PMP — Director of Clinical Implementation, LAP of America
▼ Abstract
At ASTRO 2023, LAP launched the new LUNA 3D SGRT system, supporting reproducible patient positioning and monitoring patient surface motion at LINACs and CTs. LUNA 3D streamlines workflows with a browser-based interface, features a virtual laser for swift patient setup, utilizes high-resolution stereoscopic CMOS cameras with GPU-powered calculations for accuracy and low latency, and engages patients through a coaching screen for precise dose delivery.
▼ Speaker biography
Delena Hanson
Delena Hanson is Director of Clinical Implementation for LAP Laser in the US, specializing in SGRT for the past decade. She has moved from clinical user to applications trainer to senior product manager, and is currently leading the education and application of the LUNA 3D SGRT system across North America.
Title 2: Sun Nuclear: Your Trusted Partner for Patient Safety
Greg Martin, MSc — Sun Nuclear
▼ Abstract
Sun Nuclear has been delivering independent quality assurance to the radiation treatment industry for 40 years, serving over 5,000 facilities worldwide. This presentation provides insights into key products including SunCHECK®, highlighting how they reduce risk, control costs, and improve treatment quality.
▼ Speaker biography
Greg Martin
Greg Martin is a registered clinical scientist in the UK with 5 years of clinical experience working in a 10-linac NHS radiotherapy center. He is an Honorary Lecturer and has presented poster publications at international conferences including AAPM and ESTRO.
Jan
24
2024
From Pixels to Patients: The Influence of Gaming and Smartphone Developments on Radiation Oncology
Wed 24 Jan · 12:00 GMT · 1 hour · Dr. Michael Douglass
 From Pixels to Patients: Gaming, Smartphones and AI in Radiation Oncology — Dr. Michael Douglass, Royal Adelaide Hospital
▶ Recording1 CPD point
Date & time
Wed 24 Jan 2024 · 12:00 GMT
Duration
1 hour
CPD / CE
1 CPD/CME point
Organizer
Eva Bezak
Moderator
Eva Bezak
From Pixels to Patients: The Influence of Gaming and Smartphone Developments on Radiation Oncology
Dr. Michael Douglass — Principal Medical Physicist, Royal Adelaide Hospital · Australian Bragg Centre for Proton Therapy
▼ Abstract
This presentation explores how advancements in the movie, video game, and smartphone industries have contributed to progress in radiation oncology. Topics include: how visual effects in the movie industry enabled synthetic training data for machine learning in RT; how smartphones enabled new 3D scanning methods (LiDAR, photogrammetry, NERF) for TBI, TSET, brachytherapy, and 3D printed bolus; how augmented reality revolutionized visualization of medical imaging data; and how GPU technology has impacted deep learning segmentation, auto planning, and large language models in medical physics.
▼ Speaker biography
Dr. Michael Douglass
Dr. Michael Douglass is Principal Medical Physicist at the Royal Adelaide Hospital overseeing treatment planning systems. He also works at the Australian Bragg Centre for Proton Therapy and holds an academic role at the University of Adelaide. His 40+ peer-reviewed publications span proton therapy, Monte Carlo simulations, machine learning, and 3D printing. He received the 2021 Simpson Prize for Cancer Research and the 2021 ACPSEM Boyce Worthley Young Achiever Award.
Learning objectives:
  1. Gain an understanding of optical scanning technologies including LiDAR, photogrammetry, and NERF and their applications in radiation oncology.
  2. Understand how consumer technologies (smartphones, gaming) have contributed to progress in radiation oncology.
  3. Learn about the benefits and potential applications of large language models in radiation oncology.
  4. Examine the integration of visual effects from the movie industry in creating synthetic training data for machine learning.
Convert times to your local time zone: GMT converter  ·  Certificates: certificates page  ·  ← 2025 webinars  ·  2026 webinars →